Abstract:Silver nanoparticles (AgNPs) have many applications in various fields, including biomedical applications. Due to the broad range of applications, they are considered as the leading fraction of manufactured nanoparticles. AgNPs are synthesized by different types of chemical and biological (green) methods. Previously, biologically synthesized AgNPs were considered safe for the environment and humans. However, new toxicity evidence have initiated a more careful assessment to delineate the toxicity mechanisms associated with these nanoparticles. This study demonstrates the use of aqueous gooseberry extract for AgNP preparation in a time- and cost-effective way. Ultraviolet-visible spectroscopy, X-ray diffraction, transmission electron microscopy, and dynamic light scattering confirm the formation of AgNPs, with an average size between 50 and 100 nm. Untargeted 1H-nuclear magnetic resonance-based metabolomics revealed manyfold up- and down-regulation in the concentration of 55 different classes of annotated metabolites in AgNP-exposed yeast Saccharomyces cerevisiae cells. Based on their chemical nature and cellular functions, these metabolites are classified into amino acids, glycolysis and the tricarboxylic acid (TCA) cycle, organic acids, nucleotide metabolism, urea cycle, and lipid metabolism. Transcriptome analysis revealed that the genes involved in oxidative stress mitigation maintain their expression levels, whereas the genes of the TCA cycle and lipid metabolism show drastic down-regulation upon AgNP exposure. Moreover, they can induce alteration in histone epigenetic marks by altering the methylation and acetylation of selected histone H3 and H4 proteins. Altogether, we conclude that the selected dose of biologically synthesized AgNPs impose toxicity by modulating the transcriptome, epigenome, and metabolome of eukaryotic cells, which eventually cause disequilibrium in cellular metabolism leading to toxicity.

Food Storage Material Silver Nanoparticles Interfere with DNA Replication Fidelity and Bind with DNA

Inhibition of DNA Replication Initiation by Silver Nanoclusters.

The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity

Genotoxicity Tests of Poly(Styrene-Co-Maleic Anhydride)-Coated Silver Nanoparticles in Vivo and in Vitro

Early Epigenetic Responses in the Genomic DNA Methylation Fingerprints in Cells in Response to Sublethal Exposure of Silver Nanoparticles

Preliminary Observations Of Interactions Between Nanomaterials And Genomes

Genotoxic effects of silver nanoparticles with/without coating in human liver HepG2 cells and in mice

Molecular toxicity mechanism of nanosilver

Evaluation of the Genotoxic and Oxidative Damage Potential of Silver Nanoparticles in Human NCM460 and HCT116 Cells

Silver Nanoparticles Elevate Mutagenesis of Eukaryotic Genomes

Silver Nanoparticles Induce Dna Hypomethylation Through Proteasome-Mediated Degradation Of Dna Methyltransferase 1

Fluorescent DNA-Silver nanoclusters in food safety detection: From synthesis to application

How inert is single‐stranded DNA towards DNA‐stabilized silver nanoclusters? A case study.

Mutagenesis and Resistance Development of Bacteria Challenged by Silver Nanoparticles

Bio-Inspired Silver Nanoparticles Impose Metabolic and Epigenetic Toxicity to Saccharomyces cerevisiae

Etching Silver Nanoparticles Using Dna

A New Strategy To Probe The Genotoxicity Of Silver Nanoparticles Combined With Cetylpyridine Bromide

Research on the antibacterial mechanism of medical nanosilver latex composite materials

Evaluation of biological effects of nanomaterials. Part I. Cyto- and genotoxicity of nanosilver composites applied in textile technologies

DNA-Mediated Morphological Control of Silver Nanoparticles.

Investigation of the cytotoxicity mechanism of silver nanoparticles in vitro.